Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

SRK Capital's investment thesis on Sanuwave Health, Inc. ($SNWV) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$SNWVNASDAQSanuwave Health, Inc.

BEAR

SRK Capital—SNWV

Fund Letter

Q2 2026

Published August 1, 2026

View Fund Profile

$4.71USD

+7.5% vs last month

$5.88Pitched

-19.9% since pitch

Market Cap$52.4M

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Sanuwave Health, Inc. ($SNWV) develops and commercializes patented non-invasive biological response activating medical systems, primarily its UltraMist acoustic wave therapy platform used in wound-care clinics. The fund fully...

— Sean Kirkwood

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $SNWV, and what else SRK Capital is buying.

Other pitches on $SNWV

Other investors who've written on Sanuwave Health, Inc.

No other institutional pitches found for this ticker yet.

View all $SNWV pitches →